nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Rosuvastatin—atherosclerosis	0.372	1	CbGbCtD
Zoledronate—GGPS1—connective tissue—atherosclerosis	0.00406	0.153	CbGeAlD
Zoledronate—GGPS1—cardiovascular system—atherosclerosis	0.00353	0.133	CbGeAlD
Zoledronate—GGPS1—adipose tissue—atherosclerosis	0.00311	0.117	CbGeAlD
Zoledronate—GGPS1—liver—atherosclerosis	0.00218	0.0823	CbGeAlD
Zoledronate—CA12—connective tissue—atherosclerosis	0.00189	0.0713	CbGeAlD
Zoledronate—FDPS—connective tissue—atherosclerosis	0.00187	0.0705	CbGeAlD
Zoledronate—Risedronate—PTGS2—atherosclerosis	0.00168	0.529	CrCbGaD
Zoledronate—FDPS—cardiovascular system—atherosclerosis	0.00163	0.0614	CbGeAlD
Zoledronate—Clodronate—PTGS2—atherosclerosis	0.0015	0.471	CrCbGaD
Zoledronate—FDPS—adipose tissue—atherosclerosis	0.00143	0.0541	CbGeAlD
Zoledronate—CA14—liver—atherosclerosis	0.0013	0.0492	CbGeAlD
Zoledronate—FDPS—liver—atherosclerosis	0.00101	0.038	CbGeAlD
Zoledronate—CA2—connective tissue—atherosclerosis	0.000971	0.0366	CbGeAlD
Zoledronate—Angioedema—Lovastatin—atherosclerosis	0.000849	0.00228	CcSEcCtD
Zoledronate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000846	0.00227	CcSEcCtD
Zoledronate—CA2—cardiovascular system—atherosclerosis	0.000845	0.0319	CbGeAlD
Zoledronate—Anaemia—Ezetimibe—atherosclerosis	0.000842	0.00226	CcSEcCtD
Zoledronate—Malaise—Lovastatin—atherosclerosis	0.000838	0.00225	CcSEcCtD
Zoledronate—Flushing—Pravastatin—atherosclerosis	0.000838	0.00225	CcSEcCtD
Zoledronate—Cardiac disorder—Pravastatin—atherosclerosis	0.000838	0.00225	CcSEcCtD
Zoledronate—Muscle spasms—Simvastatin—atherosclerosis	0.000836	0.00225	CcSEcCtD
Zoledronate—Vertigo—Lovastatin—atherosclerosis	0.000835	0.00224	CcSEcCtD
Zoledronate—ABCC1—adipose tissue—atherosclerosis	0.000833	0.0314	CbGeAlD
Zoledronate—Angioedema—Ezetimibe—atherosclerosis	0.000833	0.00224	CcSEcCtD
Zoledronate—Angiopathy—Niacin—atherosclerosis	0.000832	0.00224	CcSEcCtD
Zoledronate—Leukopenia—Lovastatin—atherosclerosis	0.000832	0.00224	CcSEcCtD
Zoledronate—Chills—Niacin—atherosclerosis	0.000823	0.00221	CcSEcCtD
Zoledronate—Malaise—Ezetimibe—atherosclerosis	0.000822	0.00221	CcSEcCtD
Zoledronate—Vision blurred—Simvastatin—atherosclerosis	0.000819	0.0022	CcSEcCtD
Zoledronate—Arrhythmia—Niacin—atherosclerosis	0.000819	0.0022	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000815	0.00219	CcSEcCtD
Zoledronate—Tremor—Simvastatin—atherosclerosis	0.000814	0.00219	CcSEcCtD
Zoledronate—Alopecia—Niacin—atherosclerosis	0.00081	0.00218	CcSEcCtD
Zoledronate—Chills—Pravastatin—atherosclerosis	0.00081	0.00218	CcSEcCtD
Zoledronate—Insomnia—Rosuvastatin—atherosclerosis	0.000809	0.00218	CcSEcCtD
Zoledronate—Ill-defined disorder—Simvastatin—atherosclerosis	0.000806	0.00217	CcSEcCtD
Zoledronate—Arrhythmia—Pravastatin—atherosclerosis	0.000806	0.00217	CcSEcCtD
Zoledronate—Palpitations—Ezetimibe—atherosclerosis	0.000805	0.00216	CcSEcCtD
Zoledronate—Paraesthesia—Rosuvastatin—atherosclerosis	0.000803	0.00216	CcSEcCtD
Zoledronate—Anaemia—Simvastatin—atherosclerosis	0.000803	0.00216	CcSEcCtD
Zoledronate—Malnutrition—Niacin—atherosclerosis	0.000798	0.00215	CcSEcCtD
Zoledronate—Erythema—Niacin—atherosclerosis	0.000798	0.00215	CcSEcCtD
Zoledronate—Alopecia—Pravastatin—atherosclerosis	0.000798	0.00214	CcSEcCtD
Zoledronate—Cough—Ezetimibe—atherosclerosis	0.000795	0.00214	CcSEcCtD
Zoledronate—Angioedema—Simvastatin—atherosclerosis	0.000794	0.00213	CcSEcCtD
Zoledronate—Chest pain—Lovastatin—atherosclerosis	0.000791	0.00213	CcSEcCtD
Zoledronate—Myalgia—Lovastatin—atherosclerosis	0.000791	0.00213	CcSEcCtD
Zoledronate—Arthralgia—Lovastatin—atherosclerosis	0.000791	0.00213	CcSEcCtD
Zoledronate—Anxiety—Lovastatin—atherosclerosis	0.000788	0.00212	CcSEcCtD
Zoledronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000788	0.00212	CcSEcCtD
Zoledronate—Hypertension—Ezetimibe—atherosclerosis	0.000787	0.00212	CcSEcCtD
Zoledronate—Malaise—Simvastatin—atherosclerosis	0.000784	0.00211	CcSEcCtD
Zoledronate—Discomfort—Lovastatin—atherosclerosis	0.000782	0.0021	CcSEcCtD
Zoledronate—Vertigo—Simvastatin—atherosclerosis	0.000781	0.0021	CcSEcCtD
Zoledronate—Leukopenia—Simvastatin—atherosclerosis	0.000778	0.00209	CcSEcCtD
Zoledronate—Arthralgia—Ezetimibe—atherosclerosis	0.000776	0.00209	CcSEcCtD
Zoledronate—Chest pain—Ezetimibe—atherosclerosis	0.000776	0.00209	CcSEcCtD
Zoledronate—Myalgia—Ezetimibe—atherosclerosis	0.000776	0.00209	CcSEcCtD
Zoledronate—Dry mouth—Lovastatin—atherosclerosis	0.000774	0.00208	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00077	0.00207	CcSEcCtD
Zoledronate—Dysgeusia—Pravastatin—atherosclerosis	0.000769	0.00207	CcSEcCtD
Zoledronate—Muscle spasms—Niacin—atherosclerosis	0.000767	0.00206	CcSEcCtD
Zoledronate—Discomfort—Ezetimibe—atherosclerosis	0.000767	0.00206	CcSEcCtD
Zoledronate—Pain—Rosuvastatin—atherosclerosis	0.000765	0.00206	CcSEcCtD
Zoledronate—Constipation—Rosuvastatin—atherosclerosis	0.000765	0.00206	CcSEcCtD
Zoledronate—Confusional state—Lovastatin—atherosclerosis	0.000765	0.00206	CcSEcCtD
Zoledronate—Dry mouth—Ezetimibe—atherosclerosis	0.000759	0.00204	CcSEcCtD
Zoledronate—Anaphylactic shock—Lovastatin—atherosclerosis	0.000758	0.00204	CcSEcCtD
Zoledronate—Muscle spasms—Pravastatin—atherosclerosis	0.000755	0.00203	CcSEcCtD
Zoledronate—Infection—Lovastatin—atherosclerosis	0.000753	0.00203	CcSEcCtD
Zoledronate—Vision blurred—Niacin—atherosclerosis	0.000752	0.00202	CcSEcCtD
Zoledronate—Confusional state—Ezetimibe—atherosclerosis	0.00075	0.00202	CcSEcCtD
Zoledronate—CA2—adipose tissue—atherosclerosis	0.000745	0.0281	CbGeAlD
Zoledronate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000744	0.002	CcSEcCtD
Zoledronate—Thrombocytopenia—Lovastatin—atherosclerosis	0.000742	0.002	CcSEcCtD
Zoledronate—Vision blurred—Pravastatin—atherosclerosis	0.00074	0.00199	CcSEcCtD
Zoledronate—Arthralgia—Simvastatin—atherosclerosis	0.00074	0.00199	CcSEcCtD
Zoledronate—Chest pain—Simvastatin—atherosclerosis	0.00074	0.00199	CcSEcCtD
Zoledronate—Myalgia—Simvastatin—atherosclerosis	0.00074	0.00199	CcSEcCtD
Zoledronate—Infection—Ezetimibe—atherosclerosis	0.000739	0.00199	CcSEcCtD
Zoledronate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000737	0.00198	CcSEcCtD
Zoledronate—Anxiety—Simvastatin—atherosclerosis	0.000737	0.00198	CcSEcCtD
Zoledronate—Tremor—Pravastatin—atherosclerosis	0.000736	0.00198	CcSEcCtD
Zoledronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000732	0.00197	CcSEcCtD
Zoledronate—Discomfort—Simvastatin—atherosclerosis	0.000731	0.00197	CcSEcCtD
Zoledronate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000729	0.00196	CcSEcCtD
Zoledronate—Angioedema—Niacin—atherosclerosis	0.000729	0.00196	CcSEcCtD
Zoledronate—Ill-defined disorder—Pravastatin—atherosclerosis	0.000729	0.00196	CcSEcCtD
Zoledronate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000728	0.00196	CcSEcCtD
Zoledronate—Anaemia—Pravastatin—atherosclerosis	0.000726	0.00195	CcSEcCtD
Zoledronate—Anorexia—Lovastatin—atherosclerosis	0.000723	0.00194	CcSEcCtD
Zoledronate—Skin disorder—Ezetimibe—atherosclerosis	0.000722	0.00194	CcSEcCtD
Zoledronate—Angioedema—Pravastatin—atherosclerosis	0.000718	0.00193	CcSEcCtD
Zoledronate—Vertigo—Niacin—atherosclerosis	0.000717	0.00193	CcSEcCtD
Zoledronate—Syncope—Niacin—atherosclerosis	0.000716	0.00192	CcSEcCtD
Zoledronate—Confusional state—Simvastatin—atherosclerosis	0.000715	0.00192	CcSEcCtD
Zoledronate—Leukopenia—Niacin—atherosclerosis	0.000714	0.00192	CcSEcCtD
Zoledronate—Urticaria—Rosuvastatin—atherosclerosis	0.000711	0.00191	CcSEcCtD
Zoledronate—Anaphylactic shock—Simvastatin—atherosclerosis	0.000709	0.00191	CcSEcCtD
Zoledronate—Oedema—Simvastatin—atherosclerosis	0.000709	0.00191	CcSEcCtD
Zoledronate—Malaise—Pravastatin—atherosclerosis	0.000709	0.0019	CcSEcCtD
Zoledronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000707	0.0019	CcSEcCtD
Zoledronate—Vertigo—Pravastatin—atherosclerosis	0.000706	0.0019	CcSEcCtD
Zoledronate—Palpitations—Niacin—atherosclerosis	0.000705	0.0019	CcSEcCtD
Zoledronate—Infection—Simvastatin—atherosclerosis	0.000705	0.00189	CcSEcCtD
Zoledronate—Leukopenia—Pravastatin—atherosclerosis	0.000703	0.00189	CcSEcCtD
Zoledronate—Loss of consciousness—Niacin—atherosclerosis	0.000701	0.00189	CcSEcCtD
Zoledronate—Cough—Niacin—atherosclerosis	0.000696	0.00187	CcSEcCtD
Zoledronate—Thrombocytopenia—Simvastatin—atherosclerosis	0.000694	0.00187	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000691	0.00186	CcSEcCtD
Zoledronate—Insomnia—Lovastatin—atherosclerosis	0.000686	0.00184	CcSEcCtD
Zoledronate—Cough—Pravastatin—atherosclerosis	0.000686	0.00184	CcSEcCtD
Zoledronate—Paraesthesia—Lovastatin—atherosclerosis	0.000681	0.00183	CcSEcCtD
Zoledronate—Arthralgia—Niacin—atherosclerosis	0.000679	0.00183	CcSEcCtD
Zoledronate—Myalgia—Niacin—atherosclerosis	0.000679	0.00183	CcSEcCtD
Zoledronate—Hypertension—Pravastatin—atherosclerosis	0.000678	0.00182	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000678	0.00182	CcSEcCtD
Zoledronate—Anorexia—Simvastatin—atherosclerosis	0.000676	0.00182	CcSEcCtD
Zoledronate—Dyspnoea—Lovastatin—atherosclerosis	0.000676	0.00182	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000675	0.00181	CcSEcCtD
Zoledronate—Insomnia—Ezetimibe—atherosclerosis	0.000673	0.00181	CcSEcCtD
Zoledronate—Arthralgia—Pravastatin—atherosclerosis	0.000669	0.0018	CcSEcCtD
Zoledronate—Chest pain—Pravastatin—atherosclerosis	0.000669	0.0018	CcSEcCtD
Zoledronate—Myalgia—Pravastatin—atherosclerosis	0.000669	0.0018	CcSEcCtD
Zoledronate—Paraesthesia—Ezetimibe—atherosclerosis	0.000668	0.0018	CcSEcCtD
Zoledronate—Dyspepsia—Lovastatin—atherosclerosis	0.000667	0.00179	CcSEcCtD
Zoledronate—Anxiety—Pravastatin—atherosclerosis	0.000667	0.00179	CcSEcCtD
Zoledronate—Dry mouth—Niacin—atherosclerosis	0.000664	0.00179	CcSEcCtD
Zoledronate—Dyspnoea—Ezetimibe—atherosclerosis	0.000663	0.00178	CcSEcCtD
Zoledronate—Discomfort—Pravastatin—atherosclerosis	0.000661	0.00178	CcSEcCtD
Zoledronate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000659	0.00177	CcSEcCtD
Zoledronate—Decreased appetite—Lovastatin—atherosclerosis	0.000659	0.00177	CcSEcCtD
Zoledronate—Dyspepsia—Ezetimibe—atherosclerosis	0.000655	0.00176	CcSEcCtD
Zoledronate—Fatigue—Lovastatin—atherosclerosis	0.000654	0.00176	CcSEcCtD
Zoledronate—Anaphylactic shock—Niacin—atherosclerosis	0.000651	0.00175	CcSEcCtD
Zoledronate—Oedema—Niacin—atherosclerosis	0.000651	0.00175	CcSEcCtD
Zoledronate—Pain—Lovastatin—atherosclerosis	0.000648	0.00174	CcSEcCtD
Zoledronate—Constipation—Lovastatin—atherosclerosis	0.000648	0.00174	CcSEcCtD
Zoledronate—Confusional state—Pravastatin—atherosclerosis	0.000647	0.00174	CcSEcCtD
Zoledronate—Decreased appetite—Ezetimibe—atherosclerosis	0.000647	0.00174	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000646	0.00174	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000642	0.00173	CcSEcCtD
Zoledronate—Asthenia—Rosuvastatin—atherosclerosis	0.000642	0.00173	CcSEcCtD
Zoledronate—Insomnia—Simvastatin—atherosclerosis	0.000642	0.00172	CcSEcCtD
Zoledronate—Anaphylactic shock—Pravastatin—atherosclerosis	0.000641	0.00172	CcSEcCtD
Zoledronate—Oedema—Pravastatin—atherosclerosis	0.000641	0.00172	CcSEcCtD
Zoledronate—Fatigue—Ezetimibe—atherosclerosis	0.000641	0.00172	CcSEcCtD
Zoledronate—Shock—Niacin—atherosclerosis	0.000641	0.00172	CcSEcCtD
Zoledronate—Infection—Pravastatin—atherosclerosis	0.000637	0.00171	CcSEcCtD
Zoledronate—Paraesthesia—Simvastatin—atherosclerosis	0.000637	0.00171	CcSEcCtD
Zoledronate—Pain—Ezetimibe—atherosclerosis	0.000636	0.00171	CcSEcCtD
Zoledronate—Constipation—Ezetimibe—atherosclerosis	0.000636	0.00171	CcSEcCtD
Zoledronate—Tachycardia—Niacin—atherosclerosis	0.000636	0.00171	CcSEcCtD
Zoledronate—Pruritus—Rosuvastatin—atherosclerosis	0.000633	0.0017	CcSEcCtD
Zoledronate—Skin disorder—Niacin—atherosclerosis	0.000633	0.0017	CcSEcCtD
Zoledronate—Dyspnoea—Simvastatin—atherosclerosis	0.000632	0.0017	CcSEcCtD
Zoledronate—Hyperhidrosis—Niacin—atherosclerosis	0.00063	0.00169	CcSEcCtD
Zoledronate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000628	0.00169	CcSEcCtD
Zoledronate—Feeling abnormal—Lovastatin—atherosclerosis	0.000625	0.00168	CcSEcCtD
Zoledronate—Dyspepsia—Simvastatin—atherosclerosis	0.000624	0.00168	CcSEcCtD
Zoledronate—Anorexia—Niacin—atherosclerosis	0.000621	0.00167	CcSEcCtD
Zoledronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00062	0.00167	CcSEcCtD
Zoledronate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00062	0.00167	CcSEcCtD
Zoledronate—Decreased appetite—Simvastatin—atherosclerosis	0.000617	0.00166	CcSEcCtD
Zoledronate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000613	0.00165	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000612	0.00165	CcSEcCtD
Zoledronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000612	0.00165	CcSEcCtD
Zoledronate—Fatigue—Simvastatin—atherosclerosis	0.000612	0.00164	CcSEcCtD
Zoledronate—Anorexia—Pravastatin—atherosclerosis	0.000611	0.00164	CcSEcCtD
Zoledronate—Hypotension—Niacin—atherosclerosis	0.000609	0.00164	CcSEcCtD
Zoledronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000608	0.00163	CcSEcCtD
Zoledronate—Constipation—Simvastatin—atherosclerosis	0.000607	0.00163	CcSEcCtD
Zoledronate—Pain—Simvastatin—atherosclerosis	0.000607	0.00163	CcSEcCtD
Zoledronate—Urticaria—Lovastatin—atherosclerosis	0.000602	0.00162	CcSEcCtD
Zoledronate—Abdominal pain—Lovastatin—atherosclerosis	0.000599	0.00161	CcSEcCtD
Zoledronate—Body temperature increased—Lovastatin—atherosclerosis	0.000599	0.00161	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000593	0.0016	CcSEcCtD
Zoledronate—Dizziness—Rosuvastatin—atherosclerosis	0.000592	0.00159	CcSEcCtD
Zoledronate—Urticaria—Ezetimibe—atherosclerosis	0.000591	0.00159	CcSEcCtD
Zoledronate—Insomnia—Niacin—atherosclerosis	0.000589	0.00158	CcSEcCtD
Zoledronate—Abdominal pain—Ezetimibe—atherosclerosis	0.000588	0.00158	CcSEcCtD
Zoledronate—Body temperature increased—Ezetimibe—atherosclerosis	0.000588	0.00158	CcSEcCtD
Zoledronate—Paraesthesia—Niacin—atherosclerosis	0.000585	0.00157	CcSEcCtD
Zoledronate—Feeling abnormal—Simvastatin—atherosclerosis	0.000584	0.00157	CcSEcCtD
Zoledronate—ABCC1—liver—atherosclerosis	0.000584	0.022	CbGeAlD
Zoledronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000584	0.00157	CcSEcCtD
Zoledronate—Dyspnoea—Niacin—atherosclerosis	0.000581	0.00156	CcSEcCtD
Zoledronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00058	0.00156	CcSEcCtD
Zoledronate—Insomnia—Pravastatin—atherosclerosis	0.00058	0.00156	CcSEcCtD
Zoledronate—Somnolence—Niacin—atherosclerosis	0.000579	0.00156	CcSEcCtD
Zoledronate—Paraesthesia—Pravastatin—atherosclerosis	0.000576	0.00155	CcSEcCtD
Zoledronate—Dyspepsia—Niacin—atherosclerosis	0.000573	0.00154	CcSEcCtD
Zoledronate—Dyspnoea—Pravastatin—atherosclerosis	0.000572	0.00154	CcSEcCtD
Zoledronate—Decreased appetite—Niacin—atherosclerosis	0.000566	0.00152	CcSEcCtD
Zoledronate—Dyspepsia—Pravastatin—atherosclerosis	0.000564	0.00152	CcSEcCtD
Zoledronate—Rash—Rosuvastatin—atherosclerosis	0.000564	0.00152	CcSEcCtD
Zoledronate—Dermatitis—Rosuvastatin—atherosclerosis	0.000564	0.00152	CcSEcCtD
Zoledronate—Urticaria—Simvastatin—atherosclerosis	0.000563	0.00151	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000562	0.00151	CcSEcCtD
Zoledronate—Abdominal pain—Simvastatin—atherosclerosis	0.000561	0.00151	CcSEcCtD
Zoledronate—Body temperature increased—Simvastatin—atherosclerosis	0.000561	0.00151	CcSEcCtD
Zoledronate—Headache—Rosuvastatin—atherosclerosis	0.000561	0.00151	CcSEcCtD
Zoledronate—Hypersensitivity—Lovastatin—atherosclerosis	0.000559	0.0015	CcSEcCtD
Zoledronate—Decreased appetite—Pravastatin—atherosclerosis	0.000557	0.0015	CcSEcCtD
Zoledronate—Pain—Niacin—atherosclerosis	0.000557	0.0015	CcSEcCtD
Zoledronate—Fatigue—Pravastatin—atherosclerosis	0.000553	0.00149	CcSEcCtD
Zoledronate—Pain—Pravastatin—atherosclerosis	0.000548	0.00147	CcSEcCtD
Zoledronate—Constipation—Pravastatin—atherosclerosis	0.000548	0.00147	CcSEcCtD
Zoledronate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000548	0.00147	CcSEcCtD
Zoledronate—Asthenia—Lovastatin—atherosclerosis	0.000544	0.00146	CcSEcCtD
Zoledronate—Pruritus—Lovastatin—atherosclerosis	0.000536	0.00144	CcSEcCtD
Zoledronate—Asthenia—Ezetimibe—atherosclerosis	0.000534	0.00143	CcSEcCtD
Zoledronate—Gastrointestinal pain—Niacin—atherosclerosis	0.000533	0.00143	CcSEcCtD
Zoledronate—Nausea—Rosuvastatin—atherosclerosis	0.000531	0.00143	CcSEcCtD
Zoledronate—Feeling abnormal—Pravastatin—atherosclerosis	0.000528	0.00142	CcSEcCtD
Zoledronate—Pruritus—Ezetimibe—atherosclerosis	0.000526	0.00141	CcSEcCtD
Zoledronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000524	0.00141	CcSEcCtD
Zoledronate—Hypersensitivity—Simvastatin—atherosclerosis	0.000523	0.0014	CcSEcCtD
Zoledronate—CA2—liver—atherosclerosis	0.000522	0.0197	CbGeAlD
Zoledronate—Diarrhoea—Lovastatin—atherosclerosis	0.000519	0.00139	CcSEcCtD
Zoledronate—Urticaria—Niacin—atherosclerosis	0.000517	0.00139	CcSEcCtD
Zoledronate—Abdominal pain—Niacin—atherosclerosis	0.000515	0.00138	CcSEcCtD
Zoledronate—Body temperature increased—Niacin—atherosclerosis	0.000515	0.00138	CcSEcCtD
Zoledronate—Urticaria—Pravastatin—atherosclerosis	0.000509	0.00137	CcSEcCtD
Zoledronate—Asthenia—Simvastatin—atherosclerosis	0.000509	0.00137	CcSEcCtD
Zoledronate—Diarrhoea—Ezetimibe—atherosclerosis	0.000509	0.00137	CcSEcCtD
Zoledronate—Abdominal pain—Pravastatin—atherosclerosis	0.000507	0.00136	CcSEcCtD
Zoledronate—Body temperature increased—Pravastatin—atherosclerosis	0.000507	0.00136	CcSEcCtD
Zoledronate—Pruritus—Simvastatin—atherosclerosis	0.000502	0.00135	CcSEcCtD
Zoledronate—Dizziness—Lovastatin—atherosclerosis	0.000501	0.00135	CcSEcCtD
Zoledronate—Dizziness—Ezetimibe—atherosclerosis	0.000492	0.00132	CcSEcCtD
Zoledronate—Diarrhoea—Simvastatin—atherosclerosis	0.000485	0.0013	CcSEcCtD
Zoledronate—Vomiting—Lovastatin—atherosclerosis	0.000482	0.0013	CcSEcCtD
Zoledronate—Hypersensitivity—Niacin—atherosclerosis	0.00048	0.00129	CcSEcCtD
Zoledronate—Rash—Lovastatin—atherosclerosis	0.000478	0.00129	CcSEcCtD
Zoledronate—Dermatitis—Lovastatin—atherosclerosis	0.000478	0.00128	CcSEcCtD
Zoledronate—Headache—Lovastatin—atherosclerosis	0.000475	0.00128	CcSEcCtD
Zoledronate—Vomiting—Ezetimibe—atherosclerosis	0.000473	0.00127	CcSEcCtD
Zoledronate—Hypersensitivity—Pravastatin—atherosclerosis	0.000472	0.00127	CcSEcCtD
Zoledronate—Dizziness—Simvastatin—atherosclerosis	0.000469	0.00126	CcSEcCtD
Zoledronate—Rash—Ezetimibe—atherosclerosis	0.000469	0.00126	CcSEcCtD
Zoledronate—Dermatitis—Ezetimibe—atherosclerosis	0.000469	0.00126	CcSEcCtD
Zoledronate—Asthenia—Niacin—atherosclerosis	0.000467	0.00126	CcSEcCtD
Zoledronate—Headache—Ezetimibe—atherosclerosis	0.000466	0.00125	CcSEcCtD
Zoledronate—Pruritus—Niacin—atherosclerosis	0.000461	0.00124	CcSEcCtD
Zoledronate—Asthenia—Pravastatin—atherosclerosis	0.00046	0.00124	CcSEcCtD
Zoledronate—Pruritus—Pravastatin—atherosclerosis	0.000454	0.00122	CcSEcCtD
Zoledronate—Vomiting—Simvastatin—atherosclerosis	0.000451	0.00121	CcSEcCtD
Zoledronate—Nausea—Lovastatin—atherosclerosis	0.00045	0.00121	CcSEcCtD
Zoledronate—Rash—Simvastatin—atherosclerosis	0.000447	0.0012	CcSEcCtD
Zoledronate—Dermatitis—Simvastatin—atherosclerosis	0.000447	0.0012	CcSEcCtD
Zoledronate—Diarrhoea—Niacin—atherosclerosis	0.000446	0.0012	CcSEcCtD
Zoledronate—Headache—Simvastatin—atherosclerosis	0.000444	0.00119	CcSEcCtD
Zoledronate—Nausea—Ezetimibe—atherosclerosis	0.000442	0.00119	CcSEcCtD
Zoledronate—Diarrhoea—Pravastatin—atherosclerosis	0.000439	0.00118	CcSEcCtD
Zoledronate—Dizziness—Niacin—atherosclerosis	0.000431	0.00116	CcSEcCtD
Zoledronate—Dizziness—Pravastatin—atherosclerosis	0.000424	0.00114	CcSEcCtD
Zoledronate—Nausea—Simvastatin—atherosclerosis	0.000421	0.00113	CcSEcCtD
Zoledronate—Vomiting—Niacin—atherosclerosis	0.000414	0.00111	CcSEcCtD
Zoledronate—Rash—Niacin—atherosclerosis	0.000411	0.0011	CcSEcCtD
Zoledronate—Dermatitis—Niacin—atherosclerosis	0.00041	0.0011	CcSEcCtD
Zoledronate—Headache—Niacin—atherosclerosis	0.000408	0.0011	CcSEcCtD
Zoledronate—Vomiting—Pravastatin—atherosclerosis	0.000408	0.0011	CcSEcCtD
Zoledronate—Rash—Pravastatin—atherosclerosis	0.000404	0.00109	CcSEcCtD
Zoledronate—Dermatitis—Pravastatin—atherosclerosis	0.000404	0.00109	CcSEcCtD
Zoledronate—Headache—Pravastatin—atherosclerosis	0.000402	0.00108	CcSEcCtD
Zoledronate—Nausea—Niacin—atherosclerosis	0.000387	0.00104	CcSEcCtD
Zoledronate—Nausea—Pravastatin—atherosclerosis	0.000381	0.00102	CcSEcCtD
Zoledronate—CA14—Metabolism—APOC3—atherosclerosis	0.0002	0.000886	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.0002	0.000885	CbGpPWpGaD
Zoledronate—CA14—Metabolism—LDLR—atherosclerosis	0.000199	0.000881	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA4—atherosclerosis	0.000199	0.000881	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALOX5—atherosclerosis	0.000197	0.000874	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PLA2G1B—atherosclerosis	0.000197	0.000873	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000196	0.000869	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP7A1—atherosclerosis	0.000195	0.000865	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CETP—atherosclerosis	0.000194	0.00086	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALOX5—atherosclerosis	0.00019	0.000843	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CG—atherosclerosis	0.00019	0.000843	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000186	0.000824	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000186	0.000824	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000186	0.000824	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000186	0.000824	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SCARB1—atherosclerosis	0.000186	0.000824	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000184	0.000814	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARG—atherosclerosis	0.000184	0.000813	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000182	0.000808	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000182	0.000804	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP27A1—atherosclerosis	0.000181	0.0008	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—INS—atherosclerosis	0.00018	0.000798	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000178	0.000786	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NAMPT—atherosclerosis	0.000177	0.000784	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000176	0.00078	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LIPC—atherosclerosis	0.000176	0.000779	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HMGCR—atherosclerosis	0.000176	0.000778	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOC3—atherosclerosis	0.000175	0.000774	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000175	0.000774	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LDLR—atherosclerosis	0.000174	0.00077	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLA2G2A—atherosclerosis	0.000171	0.000758	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA2—atherosclerosis	0.000171	0.000758	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALOX15—atherosclerosis	0.000171	0.000758	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALOX5AP—atherosclerosis	0.000171	0.000758	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NAMPT—atherosclerosis	0.000171	0.000756	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00017	0.000754	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CETP—atherosclerosis	0.00017	0.000752	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LIPC—atherosclerosis	0.00017	0.000751	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCG5—atherosclerosis	0.000169	0.000749	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOC3—atherosclerosis	0.000169	0.000747	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LDLR—atherosclerosis	0.000168	0.000742	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ALB—atherosclerosis	0.000165	0.000731	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000164	0.000725	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CETP—atherosclerosis	0.000164	0.000725	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPA—atherosclerosis	0.000163	0.000723	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SCARB1—atherosclerosis	0.000163	0.00072	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LDLRAP1—atherosclerosis	0.000162	0.000717	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000158	0.000701	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000158	0.000701	CbGpPWpGaD
Zoledronate—CA2—Metabolism—BGN—atherosclerosis	0.000158	0.0007	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—NOS3—atherosclerosis	0.000158	0.0007	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SCARB1—atherosclerosis	0.000157	0.000694	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCA1—atherosclerosis	0.000157	0.000693	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA5—atherosclerosis	0.000157	0.000693	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HMGCR—atherosclerosis	0.000154	0.00068	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLTP—atherosclerosis	0.000152	0.000674	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLA2G1B—atherosclerosis	0.000151	0.000667	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMGCR—atherosclerosis	0.000148	0.000656	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALOX5—atherosclerosis	0.000146	0.000645	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—atherosclerosis	0.000145	0.00064	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000141	0.000624	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00014	0.000621	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000139	0.000617	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000139	0.000613	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCA1—atherosclerosis	0.000137	0.000606	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000136	0.000602	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HMOX1—atherosclerosis	0.000134	0.000595	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG8—atherosclerosis	0.000132	0.000584	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LTA4H—atherosclerosis	0.000132	0.000584	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCA1—atherosclerosis	0.000132	0.000584	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NAMPT—atherosclerosis	0.000131	0.000578	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00013	0.000577	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LIPC—atherosclerosis	0.00013	0.000574	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000129	0.000573	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOC3—atherosclerosis	0.000129	0.000571	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOB—atherosclerosis	0.000129	0.00057	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LDLR—atherosclerosis	0.000128	0.000567	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTM1—atherosclerosis	0.000125	0.000554	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CETP—atherosclerosis	0.000125	0.000554	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000123	0.000545	CbGpPWpGaD
Zoledronate—CA14—Metabolism—LPL—atherosclerosis	0.000123	0.000544	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SCARB1—atherosclerosis	0.00012	0.000531	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPX1—atherosclerosis	0.00012	0.000531	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HMOX1—atherosclerosis	0.000117	0.00052	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CD36—atherosclerosis	0.000117	0.000517	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA4—atherosclerosis	0.000115	0.000509	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000114	0.000505	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMOX1—atherosclerosis	0.000113	0.000501	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMGCR—atherosclerosis	0.000113	0.000501	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOB—atherosclerosis	0.000112	0.000498	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—atherosclerosis	0.000111	0.00049	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00011	0.000486	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—atherosclerosis	0.000109	0.000484	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARA—atherosclerosis	0.000109	0.000481	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOB—atherosclerosis	0.000108	0.00048	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—LPL—atherosclerosis	0.000107	0.000476	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTM1—atherosclerosis	0.000106	0.000467	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AGT—atherosclerosis	0.000105	0.000465	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPX1—atherosclerosis	0.000105	0.000464	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG1—atherosclerosis	0.000104	0.000462	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LPL—atherosclerosis	0.000104	0.000459	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOE—atherosclerosis	0.000103	0.000456	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD36—atherosclerosis	0.000102	0.000452	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAV1—atherosclerosis	0.000102	0.000452	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOA1—atherosclerosis	0.000102	0.000451	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPX1—atherosclerosis	0.000101	0.000447	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCA1—atherosclerosis	0.000101	0.000447	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA2—atherosclerosis	9.9e-05	0.000438	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD36—atherosclerosis	9.84e-05	0.000436	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FABP4—atherosclerosis	9.81e-05	0.000434	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LCAT—atherosclerosis	9.81e-05	0.000434	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLG—atherosclerosis	9.7e-05	0.000429	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—atherosclerosis	9.67e-05	0.000428	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA4—atherosclerosis	9.63e-05	0.000426	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARA—atherosclerosis	9.49e-05	0.00042	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP7A1—atherosclerosis	9.46e-05	0.000419	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—atherosclerosis	9.33e-05	0.000413	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—atherosclerosis	9.3e-05	0.000412	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AGT—atherosclerosis	9.19e-05	0.000407	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARA—atherosclerosis	9.15e-05	0.000405	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BGN—atherosclerosis	9.14e-05	0.000405	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.02e-05	0.000399	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—atherosclerosis	9e-05	0.000399	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—atherosclerosis	8.97e-05	0.000397	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.95e-05	0.000396	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAV1—atherosclerosis	8.92e-05	0.000395	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOA1—atherosclerosis	8.9e-05	0.000394	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AGT—atherosclerosis	8.86e-05	0.000392	CbGpPWpGaD
Zoledronate—CA14—Metabolism—INS—atherosclerosis	8.8e-05	0.00039	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP27A1—atherosclerosis	8.74e-05	0.000387	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—atherosclerosis	8.68e-05	0.000384	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—atherosclerosis	8.66e-05	0.000383	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	8.61e-05	0.000381	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—atherosclerosis	8.6e-05	0.000381	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOA1—atherosclerosis	8.58e-05	0.00038	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOB—atherosclerosis	8.57e-05	0.000379	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	8.4e-05	0.000372	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOB—atherosclerosis	8.29e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALOX15—atherosclerosis	8.29e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA2—atherosclerosis	8.29e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLA2G2A—atherosclerosis	8.29e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALOX5AP—atherosclerosis	8.29e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG5—atherosclerosis	8.19e-05	0.000362	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.18e-05	0.000362	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—atherosclerosis	8.13e-05	0.00036	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—atherosclerosis	8.07e-05	0.000357	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—atherosclerosis	8.07e-05	0.000357	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CST3—atherosclerosis	7.97e-05	0.000353	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPL—atherosclerosis	7.92e-05	0.000351	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPA—atherosclerosis	7.91e-05	0.00035	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—atherosclerosis	7.84e-05	0.000347	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—atherosclerosis	7.84e-05	0.000347	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—atherosclerosis	7.73e-05	0.000342	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NOS3—atherosclerosis	7.72e-05	0.000342	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—INS—atherosclerosis	7.69e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BGN—atherosclerosis	7.66e-05	0.000339	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.6e-05	0.000337	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA5—atherosclerosis	7.58e-05	0.000336	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—atherosclerosis	7.56e-05	0.000335	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NAMPT—atherosclerosis	7.55e-05	0.000334	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD36—atherosclerosis	7.52e-05	0.000333	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOC3—atherosclerosis	7.45e-05	0.00033	CbGpPWpGaD
Zoledronate—CA12—Metabolism—INS—atherosclerosis	7.42e-05	0.000328	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LDLR—atherosclerosis	7.41e-05	0.000328	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.36e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLA2G1B—atherosclerosis	7.3e-05	0.000323	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—atherosclerosis	7.26e-05	0.000322	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.23e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.22e-05	0.000319	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HSPA1B—atherosclerosis	7.16e-05	0.000317	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.15e-05	0.000316	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.13e-05	0.000316	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—atherosclerosis	7.13e-05	0.000316	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—atherosclerosis	7.06e-05	0.000312	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—atherosclerosis	7.05e-05	0.000312	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALOX5—atherosclerosis	7.05e-05	0.000312	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARA—atherosclerosis	7e-05	0.00031	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCF1—atherosclerosis	6.93e-05	0.000307	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—atherosclerosis	6.8e-05	0.000301	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.78e-05	0.0003	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AGT—atherosclerosis	6.77e-05	0.0003	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—atherosclerosis	6.75e-05	0.000299	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—atherosclerosis	6.64e-05	0.000294	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—atherosclerosis	6.58e-05	0.000291	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA1—atherosclerosis	6.56e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CYBA—atherosclerosis	6.52e-05	0.000288	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.51e-05	0.000288	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—atherosclerosis	6.5e-05	0.000288	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PARP1—atherosclerosis	6.38e-05	0.000282	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAMPT—atherosclerosis	6.32e-05	0.00028	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.28e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LIPC—atherosclerosis	6.28e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOC3—atherosclerosis	6.24e-05	0.000276	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LDLR—atherosclerosis	6.21e-05	0.000275	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—atherosclerosis	6.17e-05	0.000273	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CETP—atherosclerosis	6.06e-05	0.000268	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—atherosclerosis	5.99e-05	0.000265	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—atherosclerosis	5.95e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SCARB1—atherosclerosis	5.8e-05	0.000257	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—atherosclerosis	5.78e-05	0.000256	CbGpPWpGaD
Zoledronate—CA2—Metabolism—INS—atherosclerosis	5.67e-05	0.000251	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.65e-05	0.00025	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMGCR—atherosclerosis	5.48e-05	0.000243	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.37e-05	0.000238	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—atherosclerosis	5.2e-05	0.00023	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—atherosclerosis	4.97e-05	0.00022	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.94e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCA1—atherosclerosis	4.89e-05	0.000216	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOB—atherosclerosis	4.79e-05	0.000212	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LPL—atherosclerosis	4.58e-05	0.000203	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—atherosclerosis	4.55e-05	0.000201	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCG—atherosclerosis	4.45e-05	0.000197	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—atherosclerosis	4.19e-05	0.000186	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—atherosclerosis	4.12e-05	0.000182	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOB—atherosclerosis	4.01e-05	0.000178	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFB—atherosclerosis	4.01e-05	0.000178	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—atherosclerosis	3.91e-05	0.000173	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—atherosclerosis	3.84e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPL—atherosclerosis	3.83e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—atherosclerosis	3.8e-05	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA1—atherosclerosis	3.79e-05	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—atherosclerosis	3.74e-05	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD36—atherosclerosis	3.64e-05	0.000161	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS2—atherosclerosis	3.58e-05	0.000158	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—atherosclerosis	3.55e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—atherosclerosis	3.45e-05	0.000153	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARA—atherosclerosis	3.39e-05	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGT—atherosclerosis	3.28e-05	0.000145	CbGpPWpGaD
Zoledronate—ABCC1—Disease—INS—atherosclerosis	3.28e-05	0.000145	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—atherosclerosis	3.21e-05	0.000142	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—atherosclerosis	3.18e-05	0.000141	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA1—atherosclerosis	3.18e-05	0.000141	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—atherosclerosis	3.1e-05	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—atherosclerosis	3.01e-05	0.000133	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—atherosclerosis	2.99e-05	0.000132	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—atherosclerosis	2.9e-05	0.000128	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—atherosclerosis	2.87e-05	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—atherosclerosis	2.8e-05	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—INS—atherosclerosis	2.75e-05	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—atherosclerosis	2.63e-05	0.000116	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—atherosclerosis	2.52e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—atherosclerosis	2.41e-05	0.000107	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—atherosclerosis	2.29e-05	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—atherosclerosis	2.2e-05	9.75e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—atherosclerosis	2.05e-05	9.08e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—atherosclerosis	1.96e-05	8.67e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—atherosclerosis	1.9e-05	8.41e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—atherosclerosis	1.43e-05	6.34e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—atherosclerosis	1.32e-05	5.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—atherosclerosis	1.11e-05	4.9e-05	CbGpPWpGaD
